132 related articles for article (PubMed ID: 33316386)
21. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
22. The role of Calmodulin Binding Transcription Activator 1 (CAMTA1) gene and its putative genetic partners in the human nervous system.
Alves G; Ornellas MH; Liehr T
Psychogeriatrics; 2022 Nov; 22(6):869-878. PubMed ID: 35949142
[TBL] [Abstract][Full Text] [Related]
23. Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma.
Chen Y; Deng X; Chen W; Shi P; Lian M; Wang H; Wang K; Qian D; Xiao D; Long H
Cell Death Dis; 2019 Jun; 10(6):448. PubMed ID: 31171769
[TBL] [Abstract][Full Text] [Related]
24. Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation.
Zhao N; Guo Y; Zhang M; Lin L; Zheng Z
Oncol Rep; 2010 May; 23(5):1443-7. PubMed ID: 20372862
[TBL] [Abstract][Full Text] [Related]
25. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells.
Huang N; Cheng S; Mi X; Tian Q; Huang Q; Wang F; Xu Z; Xie Z; Chen J; Cheng Y
Mol Carcinog; 2016 Nov; 55(11):1613-1626. PubMed ID: 26455908
[TBL] [Abstract][Full Text] [Related]
27. miR‑181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma.
Tang D; Gao W; Yang J; Liu J; Zhao J; Ge J; Chen Q; Liu B
Mol Med Rep; 2020 Nov; 22(5):3804-3812. PubMed ID: 33000209
[TBL] [Abstract][Full Text] [Related]
28. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
29. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
30. Integrator of Stress Responses Calmodulin Binding Transcription Activator 1 (Camta1) Regulates miR-212/miR-132 Expression and Insulin Secretion.
Mollet IG; Malm HA; Wendt A; Orho-Melander M; Eliasson L
J Biol Chem; 2016 Aug; 291(35):18440-52. PubMed ID: 27402838
[TBL] [Abstract][Full Text] [Related]
31. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
Wang Y; Gao S; Wang W; Liang J
Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
[TBL] [Abstract][Full Text] [Related]
32. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
Jiang J; Lu J; Wang X; Sun B; Liu X; Ding Y; Gao G
Aging (Albany NY); 2021 Jul; 13(15):19243-19259. PubMed ID: 34233294
[TBL] [Abstract][Full Text] [Related]
33. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.
Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S
Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656
[TBL] [Abstract][Full Text] [Related]
34. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
[TBL] [Abstract][Full Text] [Related]
35. An E3 Ubiquitin Ligase RNF139 Serves as a Tumor-Suppressor in Glioma.
Chen X; Kuang W; Zhu Y; Zhou B; Li X; Zhang X; Li B; Li L; Zou S
J Mol Neurosci; 2021 Aug; 71(8):1664-1673. PubMed ID: 34106407
[TBL] [Abstract][Full Text] [Related]
36. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis.
Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X
J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501
[TBL] [Abstract][Full Text] [Related]
37. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
[TBL] [Abstract][Full Text] [Related]
38. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
39. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
Wang M; Li C; Shi W
Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.
Bao Z; Chen L; Guo S
J Cell Biochem; 2019 Jun; 120(6):10205-10214. PubMed ID: 30592329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
